⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13404891 | 1.00 | — | — | |
| SCHEMBL10267351 | 1.00 | — | — | |
| SCHEMBL19542899 | 0.81 | — | — | |
| SCHEMBL19542881 | 0.81 | — | — | |
| SCHEMBL14365544 | 0.81 | — | — | |
| SCHEMBL16420407 | 0.81 | LMNA (0.47) | — | |
| SCHEMBL18358134 | 0.78 | — | — | |
| SCHEMBL9003945 | 0.75 | — | — | |
| SCHEMBL18235451 | 0.72 | — | — | |
| SCHEMBL10503990 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 173 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240207839-A1 | FLOW CELLS | ILLUMINA, INC. | 2024-06-27 | — | — | US | disclosed |
| US-20240210829-A1 | METHODS FOR MAKING FLOW CELLS | ILLUMINA, INC. | 2024-06-27 | — | — | US | disclosed |
| US-20240018381-A1 | NANOIMPRINT LITHOGRAPHY RESIN COMPOSITION | ILLUMINA, INC. | 2024-01-18 | — | — | US | disclosed |
| US-20240016943-A1 | SYNTHETIC DNA BINDING DOMAINS AND USES THEREOF | THE UNIVERSITY OF CHICAGO (US) | 2024-01-18 | — | — | US | disclosed |
| US-20240018381-A1 | NANOIMPRINT LITHOGRAPHY RESIN COMPOSITION | ILLUMINA, INC. | 2024-01-18 | — | — | US | disclosed |
| US-20230399514-A1 | BIOSOLVENTS USEFUL FOR IMPROVED ASPHALT PRODUCTS UTILIZING RECYCLED ASPHALT PAVEMENT OR OTHER BRITTLE ASPHALT BINDERS SUCH AS VACUUM TOWER BOTTOM | UNIV IOWA STATE RES FOUND INC (US) | 2023-12-14 | — | — | US | disclosed |
| US-20230399514-A1 | BIOSOLVENTS USEFUL FOR IMPROVED ASPHALT PRODUCTS UTILIZING RECYCLED ASPHALT PAVEMENT OR OTHER BRITTLE ASPHALT BINDERS SUCH AS VACUUM TOWER BOTTOM | UNIV IOWA STATE RES FOUND INC (US) | 2023-12-14 | — | — | US | disclosed |
| US-20230350297-A1 | METHODS FOR MAKING FLOW CELL SURFACES | ILLUMINA, INC. | 2023-11-02 | — | — | US | disclosed |
| US-20230332224-A1 | FLOW CELLS | ILLUMINA, INC. | 2023-10-19 | — | — | US | disclosed |
| US-11773265-B2 | Biosolvents useful for improved asphalt products utilizing recycled asphalt pavement or other brittle asphalt binders such as vacuum tower bottom | IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 2023-10-03 | — | — | US | disclosed |
| US-20070275436-A1 | Polyene polyketides, processes for their production and their use as a pharmaceutical | ECOPIA BIOSCIENCES, INC. | 2007-11-29 | — | — | US | disclosed |
| US-20070225265-A1 | Novel Macrocycles for the Treatment of Cancer | R&D-BIOPHARMACEUTICALS GMBH (DE) | 2007-09-27 | — | — | US | disclosed |
| US-7273885-B2 | Inhibitors of serine proteases, particularly HCV NS3-NS4A protease | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2007-09-25 | — | — | US | disclosed |
| US-20070202342-A1 | Applying to an oral surface (teeth or gums)one or more bridged polycyclic compounds comprising at least two cyclic groups defined in part by quaternary ammonium moieties; microbiocides; self-cleaning; dentistry; bonding agents, resin cements, sealants | ALLACCEM, INC. | 2007-08-30 | — | — | US | disclosed |
| US-20070161789-A1 | Inhibitors of serine proteases, particularly HCV NS3-NS4A protease | VERTEX PHARMACEUTICALS INCORPORATED | 2007-07-12 | — | — | US | disclosed |
| US-7241796-B2 | Inhibitors of serine proteases, particularly HCV NS3-NS4A protease | VERTEX PHARMACEUTICALS INC. (US) | 2007-07-10 | — | — | US | disclosed |
| US-20070105905-A1 | Novel macrocycles for the treatment of cancer | LEIBNIZ-INSTITUT FUER PFLANZENBIOCHEMIE (IPB) (DE) | 2007-05-10 | — | — | US | disclosed |
| US-20070105905-A1 | Novel macrocycles for the treatment of cancer | LEIBNIZ-INSTITUT FUER PFLANZENBIOCHEMIE (IPB) (DE) | 2007-05-10 | — | — | US | disclosed |
| US-7208600-B2 | Inhibitors of serine proteases, particularly HCV NS3-NS4A proteases | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2007-04-24 | — | — | US | disclosed |
| US-20070015735-A1 | Water-dispersible carotenoids, including analogs and derivatives | LOCKWOOD SAMUEL F | 2007-01-18 | — | — | US | disclosed |